Abstract
During normal aging and in chronic diabetes the excessive accumulation of reactive glucose-protein or glucose-lipid adducts known as advanced glycosylation endproducts (AGEs) has been shown to induce tissue dysfunction, in part through interaction with AGE-specific receptors on monocyte/macrophages and other cells. Recognizing that circulating lymphocytes trafficking through tissues interact with tissue AGEs, we searched for the expression of AGE-binding sites on peripheral blood T lymphocytes. Resting rat and human T cells bound 125I-AGE-albumin with an affinity of 7.8 x 10(7) M-1, whereas, after stimulation with phytohemagglutinin (PHA) for 48 h, binding affinity increased to 5.8 x 10(8) M-1. Flow cytometric analysis of resting rat T cells using polyclonal antibodies raised against rat liver AGE-binding proteins (p60 and p90) revealed the constitutive expression of both immunoreactivities. The number of resting CD4+ and CD8+ T cells positive for anti-p60 antibody binding (34.2 and 58.5%, respectively) increased to 92 and 90% of cells after 48-h stimulation with PHA. Exposure of PHA-activated T lymphocytes to AGE-albumin enhanced expression of interferon gamma (IFN-gamma) mRNA 10-fold and induced greater elaboration of the mature protein than did exposure to unmodified protein or PHA treatment alone. These data indicate that T cells contain an inducible system of surface receptors for AGE-modified proteins, and that receptor occupancy is linked to lymphokine production. This T cell AGE-receptor system might serve to target lymphocytes to AGE-rich tissues and involve them in the regulation of tissue homeostasis either by assisting in macrophage-dependent clearance of AGE-proteins, or by exerting direct antiproliferative action on mesenchymal cells. Under conditions of excessive AGE-protein and AGE lipid accumulation (e.g., aging and diabetes), enhanced production of AGE-induced IFN-gamma may accelerate immune responses that contribute to tissue injury.
MeSH Terms
Animals
Base Sequence
DNA Primers
Flow Cytometry
Gene Expression
Glycation End Products, Advanced/metabolism
Humans
Interferon-gamma/biosynthesis,genetics
Ligands
Lymphocyte Activation
Macrophages/chemistry
Male
Molecular Sequence Data
Monocytes/chemistry
RNA, Messenger/genetics
Rats
Rats, Sprague-Dawley
Receptors, Cell Surface/metabolism
Up-Regulation
Chemicals
DNA Primers
Glycation End Products, Advanced
Ligands
RNA, Messenger
Receptors, Cell Surface
Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Imani F
Picower Institute for Medical Research, Manhasset, New York 11030.
Horii Y
Suthanthiran M
Skolnik E Y
Makita Z
Sharma V
Sehajpal P
Vlassara H
References (28)
28 references, click to expand
-
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.
Lab Invest. 1989 Aug;61(2):166-70
PMID: 2787872
-
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.
Circ Res. 1988 Oct;63(4):712-9
PMID: 3139321
-
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
J Exp Med. 1989 Oct 1;170(4):1387-407
PMID: 2551990
-
Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.
J Exp Med. 1989 Nov 1;170(5):1595-608
PMID: 2509626
-
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
J Exp Med. 1990 Mar 1;171(3):941-6
PMID: 2307938
-
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.
Diabetes. 1990 Dec;39(12):1510-8
PMID: 2174009
-
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.
Proc Natl Acad Sci U S A. 1990 Nov;87(22):9010-4
PMID: 2247477
-
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Lab Invest. 1991 Jan;64(1):5-15
PMID: 1990208
-
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
J Exp Med. 1991 Sep 1;174(3):515-24
PMID: 1651976
-
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
J Exp Med. 1991 Oct 1;174(4):931-9
PMID: 1655949
-
Polyclonal origin of T lymphocytes in human atherosclerotic plaques.
Lab Invest. 1991 Dec;65(6):654-60
PMID: 1836515
-
T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.
Arterioscler Thromb. 1992 Feb;12(2):206-11
PMID: 1531930
-
Immunochemical detection of advanced glycosylation end products in vivo.
J Biol Chem. 1992 Mar 15;267(8):5133-8
PMID: 1371995
-
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2873-7
PMID: 1313571
-
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
J Biol Chem. 1992 Jul 25;267(21):14987-97
PMID: 1321822
-
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
J Biol Chem. 1992 Jul 25;267(21):14998-5004
PMID: 1378843
-
Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
J Clin Invest. 1992 Aug;90(2):439-46
PMID: 1322940
-
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
Scand J Clin Lab Invest Suppl. 1968;97:77-89
PMID: 4179068
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem. 1976 May 7;72:248-54
PMID: 942051
-
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57
PMID: 637870
-
Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation.
J Cell Biol. 1983 Mar;96(3):722-9
PMID: 6833380
-
Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.
J Exp Med. 1986 Oct 1;164(4):1301-9
PMID: 3760778
-
Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.
J Exp Med. 1987 Aug 1;166(2):539-49
PMID: 3598465
-
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
N Engl J Med. 1988 May 19;318(20):1315-21
PMID: 3283558
-
The interleukin 2 receptor.
Adv Immunol. 1988;42:165-79
PMID: 3129919
-
Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.
Science. 1988 Jun 10;240(4858):1546-8
PMID: 3259727
-
Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.
Arch Biochem Biophys. 1988 Jun;263(2):418-23
PMID: 3377512
-
Detection of activated T lymphocytes in the human atherosclerotic plaque.
Am J Pathol. 1989 Jul;135(1):169-75
PMID: 2505620